Results
|
541.
|
|
|
542.
|
|
|
543.
|
|
|
544.
|
|
|
545.
|
|
|
546.
|
Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer. [electronic resource] by
- Esteva, Francisco J
- Glaspy, John
- Baidas, Said
- Laufman, Leslie
- Hutchins, Laura
- Dickler, Maura
- Tripathy, Debu
- Cohen, Roger
- DeMichele, Angela
- Yocum, Richard C
- Osborne, C Kent
- Hayes, Daniel F
- Hortobagyi, Gabriel N
- Winer, Eric
- Demetri, George D
Producer: 20030410
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 21
Availability: No items available.
|
|
547.
|
|
|
548.
|
|
|
549.
|
|
|
550.
|
|
|
551.
|
Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts. [electronic resource] by
- Stabellini, Giordano
- Balducci, Chiara
- Lilli, Cinzia
- Marinucci, Lorella
- Becchetti, Ennio
- Carinci, Francesco
- Calastrini, Carla
- Dolci, Claudia
- Lumare, Eleonora
- Locci, Paola
Producer: 20090122
In:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 62
Availability: No items available.
|
|
552.
|
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. [electronic resource] by
- Johansen, Lisa M
- Brannan, Jennifer M
- Delos, Sue E
- Shoemaker, Charles J
- Stossel, Andrea
- Lear, Calli
- Hoffstrom, Benjamin G
- Dewald, Lisa Evans
- Schornberg, Kathryn L
- Scully, Corinne
- Lehár, Joseph
- Hensley, Lisa E
- White, Judith M
- Olinger, Gene G
Producer: 20140113
In:
Science translational medicine vol. 5
Availability: No items available.
|
|
553.
|
|
|
554.
|
|
|
555.
|
|
|
556.
|
|
|
557.
|
|
|
558.
|
|
|
559.
|
|
|
560.
|
|